1. Home
  2. TRIP vs MGTX Comparison

TRIP vs MGTX Comparison

Compare TRIP & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TripAdvisor Inc.

TRIP

TripAdvisor Inc.

N/A

Current Price

$14.55

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$12.32

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIP
MGTX
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
TRIP
MGTX
Price
$14.55
$12.32
Analyst Decision
Hold
Strong Buy
Analyst Count
13
7
Target Price
$14.40
$24.57
AVG Volume (30 Days)
2.6M
817.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
33.02
EPS
N/A
N/A
Revenue
$1,556,000,000.00
$81,391,000.00
Revenue This Year
$3.33
$141.38
Revenue Next Year
$5.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
144.57
52 Week Low
$9.01
$6.62
52 Week High
$20.16
$15.35

Technical Indicators

Market Signals
Indicator
TRIP
MGTX
Relative Strength Index (RSI) 60.88 51.57
Support Level $13.04 $8.84
Resistance Level $15.33 $15.35
Average True Range (ATR) 0.57 0.67
MACD -0.08 -0.20
Stochastic Oscillator 75.41 20.85

Price Performance

Historical Comparison
TRIP
MGTX

About TRIP TripAdvisor Inc.

Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: